AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 70 filers reported holding AUDENTES THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $25,234,000 | +11.0% | 660,406 | -12.7% | 0.66% | +4.1% |
| Q1 2018 | $22,724,000 | -6.9% | 756,215 | -3.2% | 0.64% | -21.4% |
| Q4 2017 | $24,416,000 | -44.2% | 781,309 | -50.0% | 0.81% | -3.2% |
| Q3 2017 | $43,770,000 | +223.4% | 1,562,618 | +120.9% | 0.84% | +22.8% |
| Q2 2017 | $13,534,000 | +10473.4% | 707,500 | +9333.3% | 0.68% | +9628.6% |
| Q1 2017 | $128,000 | -6.6% | 7,500 | 0.0% | 0.01% | -30.0% |
| Q4 2016 | $137,000 | +2.2% | 7,500 | 0.0% | 0.01% | +11.1% |
| Q3 2016 | $134,000 | – | 7,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,806,832 | $34,582,764,000 | 27.20% |
| Casdin Capital, LLC | 400,000 | $7,652,000 | 2.83% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,729,268 | $33,081,000 | 1.76% |
| Redmile Group, LLC | 1,459,616 | $27,922,000 | 1.70% |
| Opaleye Management Inc. | 150,000 | $2,869,000 | 1.20% |
| Cormorant Asset Management, LP | 323,545 | $6,189,000 | 1.03% |
| Orbimed Advisors | 4,801,638 | $91,855,000 | 0.96% |
| Perceptive Advisors | 707,500 | $13,534,000 | 0.68% |
| Rock Springs Capital Management LP | 595,200 | $11,386,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $2,870,000 | 0.49% |